AVAH Share Price Performance
US$13.16
5.69 (76.17%)
32.3% overvalued intrinsic discount
US$9.95
Fair Value
Price US$13.16
AnalystConsensusTarget US$9.95
AnalystLowTarget US$8.00
AnalystHighTarget US$16.00
Fair ValueUS$9.95
Share Pricen/a
Aveanna Healthcare Holdings Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
AVAH Community Narratives
AN
Fair Value
·Fair Value US$9.95 32.3% overvalued intrinsic discount
Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value
·Fair Value US$8 64.5% overvalued intrinsic discount
Medicaid Cuts And Rising Wages Will Erode Margins
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$16 17.8% undervalued intrinsic discount
Aging Demographics Will Expand The Home Care Market
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Demographics Will Expand The Home Care Market
Home-based care is growing fast, but providers can’t hire enough staff to keep up—and Aveanna may be one of the companies best placed to benefit as more care shifts out of facilities and into the home. The catch is that its results depend heavily on government payments, staffing costs, and policy changes that could quickly squeeze profits.Read more
AN
US$16
17.8% undervalued intrinsic discount
Fair Value
Revenue
7.57% p.a.
Profit Margin
6.37%
Future PE
23.99x
Price in 2029
US$19.92
Medicaid Cuts And Rising Wages Will Erode Margins
Aveanna depends heavily on government payments for home-based care, and tighter public budgets could make it harder to grow while pushing profits lower. At the same time, rising caregiver wages, tougher contract negotiations, and new tech-driven care options could squeeze the business—even as demand for care at home stays strong.Read more
AN
US$8
64.5% overvalued intrinsic discount
Fair Value
Revenue
5.45% p.a.
Profit Margin
5.11%
Future PE
16.39x
Price in 2029
US$10.05
Improved Earnings Visibility and Liquidity Changes Will Shape Capacity Expansion
Aveanna rides a wave of people choosing care at home, and demand is already running ahead of what it can staff and deliver. The catch is that its growth depends heavily on government payments and a tight caregiver job market, so small policy or labor shifts could quickly change the story.Read more
AN
US$9.95
32.3% overvalued intrinsic discount
Fair Value
Revenue
5.18% p.a.
Profit Margin
4.48%
Future PE
23.35x
Price in 2029
US$12.46
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
AVAH: Future Upside Will Rely On Preferred Payor Mix And Reimbursement
Fair Value: US$16 17.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AVAH: Home Care Momentum And Preferred Payor Mix Will Support Margin Resilience
Fair Value: US$8 64.5% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AVAH: Beat And Raise Execution May Support Future Repricing Potential
Fair Value: US$9.95 32.3% overvalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Aveanna Healthcare Holdings Inc. Key Details
Last Reported Earnings
Jul 04, 2026
Next Reporting Earnings
n/a
- 1.26
- 32.04%
- 10.56%
- 507.9%
About AVAH
- Founded
- 2016
- Employees
- 19500
- CEO
- WebsiteView website
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
